Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
The study is a sub-study of RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (NCT01719055). The treatment will consist of permanent implant of a Precision Spectra™ SCS IPG with either a 32 contact CoverEdge™ Surgical Lead or with more than 2 percutaneous leads after a successful trial. Programming features and lead options of the Precision Spectra™ SCS System will be evaluated up to 3 months post-IPG activation. Following completion of the 3 month visit, subjects will continue to be followed for up to 36 months per the study requirements of the RELIEF Registry.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meets RELIEF Registry criteria for inclusion
Primary complaint of persistent or recurrent low back pain, with or without leg pain
Signed a valid, IRB/EC-approved informed consent form
You may not be if
Meets any RELIEF Registry criteria for exclusion
Clareo Health | A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes
